PPARα Agonist Oral Therapy in Diabetic Retinopathy

Diabetic retinopathy (DR) is an eye condition that develops after chronically poorly-managed diabetes, and is presently the main cause for blindness on a global scale. Current treatments for DR such as laser photocoagulation, topical injection of corticosteroids, intravitreal injection of anti-vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yohei, Lee, Deokho, Tsubota, Kazuo, Kurihara, Toshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589723/
https://www.ncbi.nlm.nih.gov/pubmed/33086679
http://dx.doi.org/10.3390/biomedicines8100433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589723/
https://www.ncbi.nlm.nih.gov/pubmed/33086679
http://dx.doi.org/10.3390/biomedicines8100433

Ejemplares similares